Moderna jab does not infringe Alnylam mRNA patents, finds US court
Meanwhile, Pfizer/BioNTech are taking aim at two Moderna patents
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the IAM experts.